ZBTB7A Enhances Osteosarcoma Chemoresistance by Transcriptionally Repressing lncRNALINC00473-IL24 Activity
Chemoresistance remains a major drawback to osteosarcoma treatment. ZBTB7A, a member of the POK transcription repressor family, was shown to play an important role in tumorigenesis. However, the effect of ZBTB7A on osteosarcoma chemoresistance is completely unknown. In this study, we found that ZBTB...
Main Authors: | Lu Zhang, Yuan Wang, Xiaojie Li, Xin Xia, Na Li, Ruiping He, Hongtao He, Chuanchun Han, Wenzhi Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-11-01
|
Series: | Neoplasia: An International Journal for Oncology Research |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1476558617303068 |
Similar Items
-
The metabolic role of LncZBTB39-1:2 in the trophoblast mobility of preeclampsia
by: Yamin Liu, et al.
Published: (2018-09-01) -
MiR-193a regulates chemoresistance of human osteosarcoma cells via repression of IRS2
by: Haiyan Wang, et al.
Published: (2019-08-01) -
The role of CTGF in chemoresistance and metastasis of osteosarcoma
by: Hsiao-Chi Tsai, et al.
Published: (2014) -
LncRNA LINC00473 is involved in the progression of invasive pituitary adenoma by upregulating KMT5A via ceRNA-mediated miR-502-3p evasion
by: Junjun Li, et al.
Published: (2021-06-01) -
Hippo/YAP signaling pathway is involved in osteosarcoma chemoresistance
by: Dong-Yu Wang, et al.
Published: (2016-05-01)